Patterson Companies, Inc. (0KGB.L)
USD 31.0
(0.45%)
USD 31.0
(0.45%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 1.89 Billion USD | 7.63% |
| 2023 | 1.76 Billion USD | 3.63% |
| 2022 | 1.69 Billion USD | -4.92% |
| 2021 | 1.78 Billion USD | -4.9% |
| 2020 | 1.87 Billion USD | 5.04% |
| 2019 | 1.78 Billion USD | -11.0% |
| 2018 | 2 Billion USD | -4.9% |
| 2017 | 2.11 Billion USD | 1.66% |
| 2016 | 2.07 Billion USD | 45.03% |
| 2015 | 1.43 Billion USD | 2.91% |
| 2014 | 1.39 Billion USD | 8.62% |
| 2013 | 1.28 Billion USD | -5.99% |
| 2012 | 1.36 Billion USD | 35.82% |
| 2011 | 1 Billion USD | 2.34% |
| 2010 | 981.45 Million USD | 3.61% |
| 2009 | 947.3 Million USD | -11.6% |
| 2008 | 1.07 Billion USD | 90.98% |
| 2007 | 561.1 Million USD | -16.15% |
| 2006 | 669.19 Million USD | -0.15% |
| 2005 | 670.22 Million USD | -14.86% |
| 2004 | 787.19 Million USD | 313.68% |
| 2003 | 190.29 Million USD | -6.73% |
| 2002 | 204.01 Million USD | 45.04% |
| 2001 | 140.66 Million USD | 15.77% |
| 2000 | 121.5 Million USD | 12.4% |
| 1999 | 108.1 Million USD | 1.89% |
| 1998 | 106.1 Million USD | 29.71% |
| 1997 | 81.8 Million USD | 8.06% |
| 1996 | 75.7 Million USD | 2.16% |
| 1995 | 74.1 Million USD | 15.78% |
| 1994 | 64 Million USD | 26.98% |
| 1993 | 50.4 Million USD | -21.98% |
| 1992 | 64.6 Million USD | 3.53% |
| 1991 | 62.4 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 1.96 Billion USD | 7.26% |
| 2024 FY | 1.89 Billion USD | 7.63% |
| 2024 Q1 | 1.77 Billion USD | 0.67% |
| 2024 Q2 | 1.83 Billion USD | 3.51% |
| 2024 Q4 | 1.89 Billion USD | -3.7% |
| 2023 Q3 | 1.83 Billion USD | 0.07% |
| 2023 Q4 | 1.76 Billion USD | -4.29% |
| 2023 Q1 | 1.73 Billion USD | 1.9% |
| 2023 FY | 1.76 Billion USD | 3.63% |
| 2023 Q2 | 1.83 Billion USD | 6.18% |
| 2022 Q3 | 1.81 Billion USD | -3.78% |
| 2022 Q2 | 1.89 Billion USD | 6.81% |
| 2022 Q1 | 1.77 Billion USD | -0.93% |
| 2022 FY | 1.69 Billion USD | -4.92% |
| 2022 Q4 | 1.69 Billion USD | -6.61% |
| 2021 Q1 | 1.79 Billion USD | -4.65% |
| 2021 Q2 | 1.89 Billion USD | 5.85% |
| 2021 Q4 | 1.78 Billion USD | -6.76% |
| 2021 FY | 1.78 Billion USD | -4.9% |
| 2021 Q3 | 1.91 Billion USD | 1.06% |
| 2020 Q2 | 1.97 Billion USD | 7.07% |
| 2020 Q1 | 1.84 Billion USD | 3.21% |
| 2020 Q3 | 2.04 Billion USD | 3.28% |
| 2020 Q4 | 1.87 Billion USD | -7.97% |
| 2020 FY | 1.87 Billion USD | 5.04% |
| 2019 Q1 | 1.84 Billion USD | -8.42% |
| 2019 FY | 1.78 Billion USD | -11.0% |
| 2019 Q3 | 1.84 Billion USD | -2.16% |
| 2019 Q4 | 1.78 Billion USD | -3.2% |
| 2019 Q2 | 1.88 Billion USD | 2.6% |
| 2018 Q4 | 2 Billion USD | -9.11% |
| 2018 Q2 | 2.16 Billion USD | 2.41% |
| 2018 Q1 | 2.11 Billion USD | -0.13% |
| 2018 FY | 2 Billion USD | -4.9% |
| 2018 Q3 | 2.21 Billion USD | 2.31% |
| 2017 Q1 | 2.08 Billion USD | 0.1% |
| 2017 FY | 2.11 Billion USD | 1.66% |
| 2017 Q4 | 2.11 Billion USD | -4.28% |
| 2017 Q3 | 2.2 Billion USD | 1.08% |
| 2017 Q2 | 2.18 Billion USD | 4.95% |
| 2016 Q2 | 2.08 Billion USD | -23.37% |
| 2016 Q1 | 2.72 Billion USD | 90.13% |
| 2016 FY | 2.07 Billion USD | 45.03% |
| 2016 Q4 | 2.07 Billion USD | -5.2% |
| 2016 Q3 | 2.19 Billion USD | 5.01% |
| 2015 FY | 1.43 Billion USD | 2.91% |
| 2015 Q4 | 1.43 Billion USD | 1.18% |
| 2015 Q1 | 1.42 Billion USD | 2.42% |
| 2015 Q2 | 1.39 Billion USD | -2.31% |
| 2015 Q3 | 1.41 Billion USD | 1.66% |
| 2014 Q1 | 1.36 Billion USD | 6.49% |
| 2014 Q2 | 1.5 Billion USD | 10.39% |
| 2014 Q3 | 1.51 Billion USD | 0.8% |
| 2014 FY | 1.39 Billion USD | 8.62% |
| 2014 Q4 | 1.39 Billion USD | -8.34% |
| 2013 Q3 | 1.28 Billion USD | 1.84% |
| 2013 Q2 | 1.26 Billion USD | -5.34% |
| 2013 Q1 | 1.33 Billion USD | -2.16% |
| 2013 Q4 | 1.28 Billion USD | -0.33% |
| 2013 FY | 1.28 Billion USD | -5.99% |
| 2012 FY | 1.36 Billion USD | 35.82% |
| 2012 Q3 | 1.31 Billion USD | 32.32% |
| 2012 Q4 | 1.36 Billion USD | 3.76% |
| 2012 Q2 | 993.61 Million USD | 1.04% |
| 2012 Q1 | 983.36 Million USD | -2.1% |
| 2011 Q1 | 962.07 Million USD | -1.98% |
| 2011 Q4 | 1 Billion USD | 5.5% |
| 2011 Q3 | 952.02 Million USD | -9.21% |
| 2011 FY | 1 Billion USD | 2.34% |
| 2011 Q2 | 1.04 Billion USD | 9.0% |
| 2010 Q1 | 988.8 Million USD | 4.38% |
| 2010 FY | 981.45 Million USD | 3.61% |
| 2010 Q4 | 981.45 Million USD | 3.92% |
| 2010 Q3 | 944.46 Million USD | 1.01% |
| 2010 Q2 | 935.03 Million USD | -5.44% |
| 2009 Q2 | 1.04 Billion USD | -2.12% |
| 2009 FY | 947.3 Million USD | -11.6% |
| 2009 Q3 | 975.71 Million USD | -6.93% |
| 2009 Q4 | 947.3 Million USD | -2.91% |
| 2009 Q1 | 1.07 Billion USD | -0.05% |
| 2008 FY | 1.07 Billion USD | 90.98% |
| 2008 Q1 | 557.9 Million USD | -0.57% |
| 2008 Q2 | 563.35 Million USD | 0.98% |
| 2008 Q3 | 623.18 Million USD | 10.62% |
| 2008 Q4 | 1.07 Billion USD | 71.95% |
| 2007 Q4 | 561.1 Million USD | 2.76% |
| 2007 FY | 561.1 Million USD | -16.15% |
| 2007 Q1 | 660.69 Million USD | -1.27% |
| 2007 Q2 | 620.16 Million USD | -6.14% |
| 2007 Q3 | 546.05 Million USD | -11.95% |
| 2006 Q1 | 659.39 Million USD | -1.62% |
| 2006 Q2 | 670.63 Million USD | 1.71% |
| 2006 Q3 | 644.56 Million USD | -3.89% |
| 2006 Q4 | 669.19 Million USD | 3.82% |
| 2006 FY | 669.19 Million USD | -0.15% |
| 2005 Q2 | 753.93 Million USD | -4.11% |
| 2005 FY | 670.22 Million USD | -14.86% |
| 2005 Q4 | 670.22 Million USD | -15.25% |
| 2005 Q3 | 790.79 Million USD | 4.89% |
| 2005 Q1 | 786.26 Million USD | -0.12% |
| 2004 Q1 | 214.69 Million USD | 12.83% |
| 2004 Q3 | 753.08 Million USD | 4.76% |
| 2004 Q4 | 787.19 Million USD | 4.53% |
| 2004 FY | 787.19 Million USD | 313.68% |
| 2004 Q2 | 718.89 Million USD | 234.84% |
| 2003 Q1 | 177.53 Million USD | -12.98% |
| 2003 FY | 190.29 Million USD | -6.73% |
| 2003 Q4 | 190.29 Million USD | 11.39% |
| 2003 Q3 | 170.82 Million USD | 3.67% |
| 2003 Q2 | 164.77 Million USD | -7.19% |
| 2002 Q2 | 151.77 Million USD | -6.76% |
| 2002 Q4 | 204.01 Million USD | 29.88% |
| 2002 Q3 | 157.07 Million USD | 3.5% |
| 2002 FY | 204.01 Million USD | 45.04% |
| 2002 Q1 | 162.77 Million USD | 15.72% |
| 2001 FY | 140.66 Million USD | 15.77% |
| 2001 Q4 | 140.66 Million USD | 8.73% |
| 2001 Q3 | 129.36 Million USD | 3.1% |
| 2001 Q1 | 128.73 Million USD | 5.95% |
| 2001 Q2 | 125.47 Million USD | -2.53% |
| 2000 Q1 | 103 Million USD | -4.72% |
| 2000 Q4 | 121.5 Million USD | 11.27% |
| 2000 FY | 121.5 Million USD | 12.4% |
| 2000 Q3 | 109.2 Million USD | -3.7% |
| 2000 Q2 | 113.4 Million USD | 10.1% |
| 1999 Q1 | 102 Million USD | -3.86% |
| 1999 Q4 | 108.1 Million USD | 13.31% |
| 1999 FY | 108.1 Million USD | 1.89% |
| 1999 Q2 | 91.7 Million USD | -10.1% |
| 1999 Q3 | 95.4 Million USD | 4.03% |
| 1998 Q3 | 85.4 Million USD | -1.5% |
| 1998 Q4 | 106.1 Million USD | 24.24% |
| 1998 FY | 106.1 Million USD | 29.71% |
| 1998 Q1 | 71 Million USD | -13.2% |
| 1998 Q2 | 86.7 Million USD | 22.11% |
| 1997 FY | 81.8 Million USD | 8.06% |
| 1997 Q2 | 85.4 Million USD | 28.61% |
| 1997 Q1 | 66.4 Million USD | -12.29% |
| 1997 Q4 | 81.8 Million USD | -8.09% |
| 1997 Q3 | 89 Million USD | 4.22% |
| 1996 Q4 | 75.7 Million USD | 0.4% |
| 1996 Q1 | 66.3 Million USD | -10.53% |
| 1996 Q2 | 61.1 Million USD | -7.84% |
| 1996 Q3 | 75.4 Million USD | 23.4% |
| 1996 FY | 75.7 Million USD | 2.16% |
| 1995 Q3 | 71.4 Million USD | 13.88% |
| 1995 Q4 | 74.1 Million USD | 3.78% |
| 1995 FY | 74.1 Million USD | 15.78% |
| 1995 Q1 | 34.2 Million USD | -46.56% |
| 1995 Q2 | 62.7 Million USD | 83.33% |
| 1994 Q3 | 70.5 Million USD | 17.11% |
| 1994 Q2 | 60.2 Million USD | 42.65% |
| 1994 Q4 | 64 Million USD | -9.22% |
| 1994 Q1 | 42.2 Million USD | -16.27% |
| 1994 FY | 64 Million USD | 26.98% |
| 1993 Q3 | 47.9 Million USD | -29.77% |
| 1993 Q4 | 50.4 Million USD | 5.22% |
| 1993 Q2 | 68.2 Million USD | 0.0% |
| 1993 FY | 50.4 Million USD | -21.98% |
| 1992 Q4 | 64.6 Million USD | 0.0% |
| 1992 FY | 64.6 Million USD | 3.53% |
| 1991 FY | 62.4 Million USD | 0.0% |
| 1991 Q4 | 62.4 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Phreesia, Inc. | 119.63 Million USD | -1483.971% |
| Accuray Incorporated | 423.54 Million USD | -347.416% |
| Align Technology, Inc. | 2.45 Billion USD | 22.76% |
| Elevance Health Inc. | 69.52 Billion USD | 97.274% |
| AxoGen, Inc. | 101.16 Million USD | -1773.233% |
| Boston Scientific Corporation | 15.6 Billion USD | 87.857% |
| CVS Health Corporation | 173.09 Billion USD | 98.905% |
| Cardinal Health, Inc. | 48.33 Billion USD | 96.079% |
| Centene Corporation | 58.68 Billion USD | 96.771% |
| DaVita Inc. | 14.87 Billion USD | 87.261% |
| HCA Healthcare, Inc. | 55.15 Billion USD | 96.564% |
| Hologic, Inc. | 4.02 Billion USD | 52.931% |
| Humana Inc. | 30.74 Billion USD | 93.837% |
| IDEXX Laboratories, Inc. | 1.77 Billion USD | -6.737% |
| Laboratory Corporation of America Holdings | 8.83 Billion USD | 78.55% |
| Masimo Corporation | 1.67 Billion USD | -13.02% |
| McKesson Corporation | 69.04 Billion USD | 97.255% |
| Quest Diagnostics Incorporated | 7.6 Billion USD | 75.079% |
| ResMed Inc. | 2 Billion USD | 5.644% |
| Henry Schein, Inc. | 5.42 Billion USD | 65.037% |
| Teladoc Health, Inc. | 2.06 Billion USD | 8.29% |
| Universal Health Services, Inc. | 8.15 Billion USD | 76.763% |
| Veeva Systems Inc. | 1.26 Billion USD | -49.673% |
| Baxter International Inc. | 19.8 Billion USD | 90.433% |
| Becton, Dickinson and Company | 26.98 Billion USD | 92.977% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | 7.299% |
| Danaher Corporation | 30.99 Billion USD | 93.887% |
| Stryker Corporation | 21.31 Billion USD | 91.111% |
| Medtronic plc | 39.56 Billion USD | 95.21% |